Ma Jianping, Liu PinYi, Pan Lili
Surgery of Breast Cancer, The Fifth People'S Hospital of Qinghai Province, Xining, 810000, Qinghai, China.
Oncology Department, Baotou Central Hospital, Botou, 014040, Inner Mongolia, China.
Discov Oncol. 2025 Feb 23;16(1):228. doi: 10.1007/s12672-025-01951-3.
Chrysin is one of the natural flavonoid compounds Sourced from various plant source, mainly in propolis and honey, demonstrates effective Cancer-suppressing properties, particularly in Breast cancer (BC). However, the specific molecular mechanisms underlying its efficacy in breast cancer treatment have remained elusive. This study employed network pharmacology combined with a molecular docking approach to uncover the intricate details of Chrysin's impact on breast cancer. Utilizing databases such as GeneCards, and disgenet, Pharmmapper, ctd database, Chrysin and potential breast cancer targets were meticulously curated. Through a strategic process of mapping and screening, core targets essential for Chrysin's efficacy in breast cancer treatment were identified. Further refinement through Venn diagram analysis, considering 1350 breast cancer target genes and 433 Chrysin-related targets, identified 140 intersection targets. Subsequent construction of protein-protein interaction networks of 140 intersecting using the STRING and Cytoscape software highlighted these ten targets as core candidates. Functional annotation and pathway analysis, performed using the ShinyGO database, unveiled that the key targets were significantly associated with the Prostate cancer pathways and IL17 signaling pathways. Molecular docking results underscored Chrysin's effective binding to these ten key targets, forming stable protein-ligand complexes. Molecular docking analyses were then conducted to evaluate the impact of Chrysin in the key targets, revealing TP53, JUN, HIF1A, ALB, CASP3, STAT3, BCL2, TNF, AKT1, and IL6 as pivotal players. In summary, this investigation provides valuable revelations into the essential targets and molecular processes through which Chrysin exerts its anti-breast cancer effects. These findings not only enhance our understanding of Chrysin's pharmacological actions in breast cancer but also lay a theoretical groundwork for future investigations into the therapeutic mechanisms of Chrysin in this context.
白杨素是一种天然黄酮类化合物，来源于多种植物，主要存在于蜂胶和蜂蜜中，具有有效的抗癌特性，尤其是对乳腺癌（BC）。然而，其在乳腺癌治疗中发挥功效的具体分子机制仍不清楚。本研究采用网络药理学结合分子对接方法，以揭示白杨素对乳腺癌影响的复杂细节。利用诸如GeneCards、disgenet、Pharmmapper、ctd数据库等，精心筛选了白杨素和潜在的乳腺癌靶点。通过映射和筛选的策略性过程，确定了白杨素在乳腺癌治疗中发挥功效所必需的核心靶点。通过维恩图分析进一步优化，考虑1350个乳腺癌靶基因和433个与白杨素相关的靶点，确定了140个交集靶点。随后使用STRING和Cytoscape软件构建这140个交集靶点的蛋白质-蛋白质相互作用网络，突出显示这十个靶点为核心候选靶点。使用ShinyGO数据库进行功能注释和通路分析，发现关键靶点与前列腺癌通路和IL17信号通路显著相关。分子对接结果强调了白杨素与这十个关键靶点的有效结合，形成稳定的蛋白质-配体复合物。然后进行分子对接分析以评估白杨素对关键靶点的影响，揭示TP53、JUN、HIF1A、ALB、CASP3、STAT3、BCL2、TNF、AKT1和IL6是关键参与者。总之，本研究为白杨素发挥抗乳腺癌作用的关键靶点和分子过程提供了有价值的启示。这些发现不仅增进了我们对白杨素在乳腺癌中药理作用的理解，也为今后在此背景下对白杨素治疗机制的研究奠定了理论基础。
